Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Treasury Shares (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Treasury Shares for 4 consecutive years, with $51810.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 17.06% to $51810.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51810.0 through Dec 2025, up 17.06% year-over-year, with the annual reading at $51810.0 for FY2025, 17.06% up from the prior year.
  • Treasury Shares for Q4 2025 was $51810.0 at bioAffinity Technologies, roughly flat from $51849.0 in the prior quarter.
  • The five-year high for Treasury Shares was $1.6 million in Q1 2025, with the low at $44261.0 in Q4 2024.
  • Average Treasury Shares over 4 years is $700482.4, with a median of $713093.5 recorded in 2023.
  • The sharpest move saw Treasury Shares soared 370.74% in 2023, then crashed 95.77% in 2025.
  • Over 4 years, Treasury Shares stood at $114920.0 in 2022, then soared by 370.74% to $540969.0 in 2023, then tumbled by 91.82% to $44261.0 in 2024, then rose by 17.06% to $51810.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $51810.0, $51849.0, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.